rss
Br J Ophthalmol 2005;89:36-39 doi:10.1136/bjo.2004.044305
  • Clinical science
    • Extended reports

Epidemiology of the optic nerve grey crescent in the Reykjavik Eye Study

  1. O Jonsson1,
  2. K F Damji2,
  3. F Jonasson3,
  4. A Arnarsson3,
  5. T Eysteinsson4,
  6. H Sasaki5 and
  7. K Sasaki5
  1. 1Department of Ophthalmology, Sahlgrenska University Hospital, Gothenburg, Sweden
  2. 2University of Ottawa Eye Institute and Ottawa Health Research Institute, Ottawa, Canada
  3. 3Department of Ophthalmology, University of Iceland, Reykjavik, Iceland
  4. 4Department of Physiology, University of Iceland, Reykjavik, Iceland
  5. 5Kanazawa Medical University, Uchinada, Japan
  1. Correspondence to: Karim F Damji University of Ottawa Eye Institute, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6; kdamjiohri.ca
  • Accepted 10 May 2004

Abstract

Aim: To establish the epidemiology of the grey crescent in a white population within the age range most susceptible to glaucoma.

Methods: Bruce Shields was first to use this term to describe a localised, physiological pigmentation of the optic nerve neuroretinal rim tissue that is distinct from peripapillary pigmentation. An experienced glaucomatologist (KFD) evaluated stereofundus photographs of the participants of the Reykjavik Eye Study (RES)—a random sample from the national population census including people 50 years and older. 1012 right eyes could be evaluated for grey crescent.

Results: The prevalence of grey crescent in the right eyes was 22.0% (95% CI 10 to 25). It was more commonly found in women (27.0%: 95% CI 23 to 30) than in men (17.0%: 95% CI 14 to 21), and was most often located temporally (36.9%), 360° (15.9%), or nasally (15.4%). The spherical equivalent was +1.30 dioptres (D) for those with and +0.80 D for those without grey crescent (p = 0.002), respectively. Vertical optic disc diameters were 0.203 v 0.195 units (p<0.001). There was no difference in the prevalence of grey crescent in glaucomatous or non-glaucomatous eyes (OR = 1.05, 95% CI 0.49 to 2.26). The prevalence of a grey crescent was inversely related to the prevalence of peripapillary atrophy (p = 0.001).

Conclusions: The grey crescent needs to be recognised as a physiological variant in order to avoid falsely labelling eyes as having glaucomatous optic nerve damage.

Notes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.